Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,704 | 1,049 | 97.8% |
| Education | $501.14 | 8 | 2.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33.21 | 2 | 0.1% |
| Gift | $12.77 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $5,475 | 286 | $0 (2024) |
| ABBVIE INC. | $2,463 | 119 | $0 (2024) |
| EMD Serono, Inc. | $1,752 | 56 | $0 (2024) |
| Biogen, Inc. | $1,411 | 41 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,383 | 50 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,268 | 39 | $0 (2024) |
| Allergan, Inc. | $1,037 | 49 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $735.19 | 52 | $0 (2024) |
| SK Life Science, Inc. | $670.58 | 10 | $0 (2024) |
| Celgene Corporation | $492.83 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,021 | 198 | Teva Pharmaceuticals USA, Inc. ($1,027) |
| 2023 | $5,215 | 202 | Teva Pharmaceuticals USA, Inc. ($1,123) |
| 2022 | $3,898 | 158 | Teva Pharmaceuticals USA, Inc. ($1,222) |
| 2021 | $3,134 | 166 | Teva Pharmaceuticals USA, Inc. ($933.23) |
| 2020 | $1,592 | 101 | Teva Pharmaceuticals USA, Inc. ($539.31) |
| 2019 | $2,484 | 109 | EMD Serono, Inc. ($791.74) |
| 2018 | $1,127 | 43 | Abbott Laboratories ($407.88) |
| 2017 | $2,780 | 83 | Biogen, Inc. ($445.98) |
All Payment Transactions
1,060 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $110.82 | General |
| 12/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: PAIN | ||||||
| 11/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: PAIN | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 837 | 1,200 | $321,380 | $123,999 |
| 2022 | 14 | 767 | 956 | $276,785 | $104,126 |
| 2021 | 14 | 790 | 972 | $304,150 | $116,914 |
| 2020 | 13 | 783 | 929 | $283,025 | $104,757 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 242 | 466 | $74,560 | $31,672 | 42.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 184 | 194 | $58,200 | $20,721 | 35.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 49 | 114 | $55,290 | $20,474 | 37.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 138 | 165 | $37,950 | $16,843 | 44.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 103 | $33,475 | $15,158 | 45.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $16,560 | $6,728 | 40.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 39 | 42 | $13,230 | $3,583 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $8,900 | $2,871 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 29 | $4,785 | $2,267 | 47.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 14 | 14 | $9,590 | $2,242 | 23.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 17 | 17 | $8,840 | $1,440 | 16.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 161 | 168 | $50,270 | $19,297 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 123 | $39,975 | $17,967 | 44.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 173 | 262 | $41,920 | $16,094 | 38.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 50 | 85 | $41,225 | $15,931 | 38.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 100 | 109 | $25,070 | $9,607 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 48 | 48 | $22,080 | $8,671 | 39.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 41 | 43 | $13,545 | $4,053 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 36 | $5,940 | $2,980 | 50.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 16 | 16 | $10,960 | $2,494 | 22.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 16 | 16 | $8,320 | $2,072 | 24.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $9,020 | $1,942 | 21.5% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $3,900 | $1,388 | 35.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 11 | 14 | $2,940 | $880.34 | 29.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 12 | 12 | $1,620 | $749.53 | 46.3% |
About Dr. Jamuna Rajasingham, M.D
Dr. Jamuna Rajasingham, M.D is a Neurology healthcare provider based in Englewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1073756474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamuna Rajasingham, M.D has received a total of $25,251 in payments from pharmaceutical and medical device companies, with $5,021 received in 2024. These payments were reported across 1,060 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($24,704).
As a Medicare-enrolled provider, Rajasingham has provided services to 3,177 Medicare beneficiaries, totaling 4,057 services with total Medicare billing of $449,795. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Englewood, NJ
- Active Since 04/14/2009
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1073756474
Products in Payments
- AJOVY (Biological) $1,617
- Austedo XR (Drug) $1,489
- AUSTEDO (Drug) $1,322
- NUPLAZID (Drug) $1,163
- INGREZZA (Drug) $1,013
- BOTOX (Biological) $951.55
- UBRELVY (Drug) $942.86
- Mavenclad (Biological) $780.49
- ZEPOSIA (Drug) $768.22
- TYSABRI (Biological) $714.15
- QULIPTA (Drug) $580.07
- NURTEC ODT (Drug) $493.90
- Hizentra (Biological) $480.04
- KESIMPTA (Drug) $447.03
- Infinity DBS Pulse Generators (Device) $445.20
- XCOPRI (Drug) $438.42
- COPAXONE (Drug) $436.66
- REXULTI (Drug) $378.66
- Duopa (Drug) $311.48
- Leqembi (Drug) $309.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Englewood
Dr. Rajeev Kumar, Md, MD
Neurology — Payments: $1.4M
Dr. Marc Treihaft, Md, MD
Neurology — Payments: $672,184
Beverly Gilder, Md, MD
Neurology — Payments: $666,331
Cori Millen, D.o, D.O
Neurology — Payments: $325,077
Rikki Racela, Md, MD
Neurology — Payments: $134,214
Monique Giroux, Md, MD
Neurology — Payments: $85,901